These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 24484207)

  • 1. Inflammation and allergy. Editorial.
    Tunctan B
    Antiinflamm Antiallergy Agents Med Chem; 2014 Mar; 13(1):1-2. PubMed ID: 24484207
    [No Abstract]   [Full Text] [Related]  

  • 2. Progress in the development of small molecule therapeutics targeting Th17 cell function for the treatment of immune-inflammatory diseases.
    Shuttleworth S; Townsend P; Silva F; Cecil A; Hill T; Tomassi C; Rogers H; Harrison R
    Prog Med Chem; 2011; 50():109-33. PubMed ID: 21315929
    [No Abstract]   [Full Text] [Related]  

  • 3. The plant extract Isatis tinctoria L. extract (ITE) inhibits allergen-induced airway inflammation and hyperreactivity in mice.
    Brattström A; Schapowal A; Kamal MA; Maillet I; Ryffel B; Moser R
    Phytomedicine; 2010 Jul; 17(8-9):551-6. PubMed ID: 20092989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Overview of Published Papers and Important Developments in the Past Three Years.
    Tunctan B
    Antiinflamm Antiallergy Agents Med Chem; 2015; 14(1):2-12. PubMed ID: 25634575
    [No Abstract]   [Full Text] [Related]  

  • 5. Insamhodo-tang, a traditional Korean medicine, regulates mast cell-mediated allergic inflammation in vivo and in vitro.
    Kim SJ; Kee JY; Choi IY; Kim MC; Kim DS; Jeon YD; Kim SG; Kim BS; Jung HJ; Kim HM; Hong SH; Um JY
    J Ethnopharmacol; 2011 Mar; 134(2):339-47. PubMed ID: 21184820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2nd International Conference on Immune-Mediated Diseases & 8th International Anti-Inflammation Meeting.
    Braddock M
    Expert Opin Investig Drugs; 2004 May; 13(5):555-64. PubMed ID: 15155131
    [No Abstract]   [Full Text] [Related]  

  • 7. Mediators and nonsteroid antiinflammatory drugs in immunologically specific and nonspecific inflammatory processes.
    Gieldanowski J; Pelczarska A
    Arch Immunol Ther Exp (Warsz); 1971; 19(1):123-33. PubMed ID: 4927481
    [No Abstract]   [Full Text] [Related]  

  • 8. Eosinophils in allergy and related diseases. Preface.
    Fujisawa T
    Int Arch Allergy Immunol; 2008; 146 Suppl 1():1. PubMed ID: 18504397
    [No Abstract]   [Full Text] [Related]  

  • 9. Allergy, Allergic Inflammation and Asthma--Keystone Symposium. Pharmacological targets in allergic inflammation and asthma.
    Kierstein S
    IDrugs; 2006 Jun; 9(6):405-8. PubMed ID: 16752308
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-inflammatory neuropeptide receptors: new therapeutic targets for immune disorders?
    Gonzalez-Rey E; Delgado M
    Trends Pharmacol Sci; 2007 Sep; 28(9):482-91. PubMed ID: 17688953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discontinued drugs for pulmonary, allergy, gastrointestinal, arthritis (2012).
    Antoniu SA
    Expert Opin Investig Drugs; 2013 Nov; 22(11):1453-64. PubMed ID: 24024675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A standardized aqueous extract of Anoectochilus formosanus modulated airway hyperresponsiveness in an OVA-inhaled murine model.
    Hsieh CC; Hsiao HB; Lin WC
    Phytomedicine; 2010 Jul; 17(8-9):557-62. PubMed ID: 20092984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation, allergy and asthma, complex immune origin diseases: mechanisms and therapeutic agents.
    Naik SR; Wala SM
    Recent Pat Inflamm Allergy Drug Discov; 2013 Jan; 7(1):62-95. PubMed ID: 23140569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symposium new drugs for inflammatory, allergic and immunologic disease.
    Summers JB; Dyer RD
    Agents Actions Suppl; 1998; 49():45-7. PubMed ID: 9426827
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-inflammatory activities of Aller-7, a novel polyherbal formulation for allergic rhinitis.
    Pratibha N; Saxena VS; Amit A; D'Souza P; Bagchi M; Bagchi D
    Int J Tissue React; 2004; 26(1-2):43-51. PubMed ID: 15573692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New trends in immunodermatology and treatment of skin diseases].
    Nordlind K; Vahlquist A
    Lakartidningen; 1999 Feb; 96(8):876-81. PubMed ID: 10089731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of non-antibiotic macrolide that corrects inflammation-driven immune dysfunction in models of inflammatory bowel diseases and arthritis.
    Mencarelli A; Distrutti E; Renga B; Cipriani S; Palladino G; Booth C; Tudor G; Guse JH; Hahn U; Burnet M; Fiorucci S
    Eur J Pharmacol; 2011 Aug; 665(1-3):29-39. PubMed ID: 21554873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update upon efficacy and safety of TNF-α inhibitors.
    Murdaca G; Colombo BM; Cagnati P; Gulli R; Spanò F; Puppo F
    Expert Opin Drug Saf; 2012 Jan; 11(1):1-5. PubMed ID: 22010813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic administration of Rosmarinus officinalis attenuates the inflammatory response induced by carrageenan in the mouse model of pleurisy.
    da Rosa JS; Facchin BM; Bastos J; Siqueira MA; Micke GA; Dalmarco EM; Pizzolatti MG; Fröde TS
    Planta Med; 2013 Nov; 79(17):1605-14. PubMed ID: 24288274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase 2 controversy: thoughts on the process of discovery, development, and assessment of benefit and risk of therapies for chronic immunoinflammatory diseases of uncertain autoimmune etiology.
    Furst DE; Khanna D; Paulus HE
    Arthritis Rheum; 2006 Oct; 55(5):683-6. PubMed ID: 17013849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.